Skip to main content
    C

    Cryoport Inc (CYRX)

    Official site

    INDUSTRIALS • INTEGRATED FREIGHT & LOGISTICS • NASDAQ

    $19.80
    -0.09 (-0.45%)

    Market Cap: $1.01B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cryoport Inc (CYRX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Cryoport (CYRX) is expected to report earnings on Mar 1, 2027. In the quarter ended Sep 30, 2026, Cryoport reported EPS of -$0.25, below the -$0.19 estimate. It beat the EPS estimate in 2 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    30%(12/40)
    Avg Surprise
    -29.53%

    Upcoming Estimates

    Reports Mar 1, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.18
    Range-$0.20 - -$0.17
    11 analysts
    Revenue Consensus
    $53.00M
    Range$49.03M - $62.95M
    11 analysts
    Reports May 3, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.17
    Range-$0.20 - -$0.13
    3 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.18+3.8%
    60d ago-$0.18+3.8%
    30d ago-$0.18+3.8%
    7d ago-$0.17+1.9%
    Current-$0.17
    Revenue Consensus
    $52.65M
    Range$52.00M - $53.26M
    7 analysts

    Next Report

    CYRX has an expected report date of Mar 1, 2027.

    CYRX Earnings Call

    The latest CYRX earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CYRX beat 12, missed 23 and matched 5. Revenue for the quarter ended Sep 30, 2026 was $50.22M, up 13.5% from $44.23M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.25-$0.19N/A-31.58%MissN/A30 up, 1 downNov 5, 2026$50.22M
    Jun 30, 2026-$0.20-$0.20-$0.20 - -$0.170.00%In lineN/A31 up, 0 downAug 6, 2026$48.97M
    Mar 31, 2026-$0.19-$0.19-$0.22 - -$0.160.00%In lineN/A40 up, 3 downMay 4, 2026$47.80M
    Dec 31, 2025-$0.17-$0.21-$0.24 - -$0.18+19.96%BeatN/A40 up, 1 downMar 3, 2026$45.45M
    Sep 30, 2025-$0.13-$0.19-$0.20 - -$0.18+31.58%BeatN/A4N/ANov 4, 2025$44.23M
    Jun 30, 2025-$0.24-$0.22-$0.28 - -$0.18-9.09%MissN/A41 up, 1 downAug 5, 2025$45.45M
    Mar 31, 2025-$0.38-$0.26-$0.38 - -$0.17-46.15%MissN/A30 up, 1 downMay 7, 2025$41.04M
    Dec 31, 2024-$0.43-$0.31-$0.33 - -$0.29-39.39%MissN/A40 up, 2 downMar 4, 2025$59.53M
    Sep 30, 2024-$0.21-$0.22-$0.36 - -$0.15+4.55%BeatN/A91 up, 1 downNov 7, 2024$56.66M
    Jun 30, 2024-$0.30-$0.40-$0.45 - -$0.33+25.00%BeatN/A100 up, 1 downAug 6, 2024$39.71M
    Mar 31, 2024-$0.42-$0.37-$0.42 - -$0.19-13.51%MissN/A101 up, 1 downMay 7, 2024$37.29M
    Dec 31, 2023-$1.31-$0.29-$0.38 - -$0.07-351.72%MissN/A100 up, 0 downMar 12, 2024$57.26M
    Sep 30, 2023-$0.41-$0.29-$0.38 - -$0.18-41.38%MissN/A90 up, 0 downNov 8, 2023$56.16M
    Jun 30, 2023-$0.33-$0.23-$0.34 - -$0.11-43.48%MissN/A90 up, 0 downAug 9, 2023$57.02M
    Mar 31, 2023-$0.13-$0.25-$0.29 - -$0.04+48.00%BeatN/A90 up, 0 downMay 4, 2023$62.82M
    Dec 31, 2022-$0.24-$0.19-$0.26 - -$0.10-26.32%MissN/A90 up, 0 downFeb 23, 2023$60.36M
    Sep 30, 2022-$0.14-$0.15-$0.18 - -$0.06+6.67%BeatN/A90 up, 0 downNov 3, 2022$60.46M
    Jun 30, 2022-$0.22-$0.20-$0.23 - -$0.07-10.00%MissN/A90 up, 1 downAug 4, 2022$64.15M
    Mar 31, 2022-$0.30-$0.30-$0.36 - -$0.110.00%In lineN/A81 up, 3 downMay 5, 2022$52.30M
    Dec 31, 2021-$0.11-$0.14-$0.19 - -$0.02+21.43%BeatN/A90 up, 0 downFeb 24, 2022$56.44M
    Sep 30, 2021-$0.15-$0.07-$0.18 - -$0.05-114.29%MissN/A9N/ANov 4, 2021$56.69M
    Jun 30, 2021-$0.14-$0.06N/A-133.33%MissN/A8N/AAug 5, 2021$56.19M
    Mar 31, 2021-$0.11-$0.05-$0.26 - $0.06-120.00%MissN/A8N/AMay 4, 2021$53.28M
    Dec 31, 2020-$0.26-$0.11-$0.31 - $0.04-136.36%MissN/A7N/AMar 1, 2021$48.36M
    Sep 30, 2020-$0.14-$0.13-$0.15 - -$0.10-7.69%MissN/A5N/ANov 5, 2020$11.17M
    Jun 30, 2020-$0.15-$0.11-$0.14 - -$0.08-36.36%MissN/A6N/AAug 6, 2020$9.39M
    Mar 31, 2020-$0.11-$0.05-$0.07 - -$0.03-120.00%MissN/A7N/AMay 7, 2020$9.77M
    Dec 31, 2019-$0.05-$0.07-$0.09 - -$0.06+28.57%BeatN/A7N/AMar 5, 2020$9.24M
    Sep 30, 2019-$0.05-$0.07-$0.10 - -$0.06+28.57%BeatN/A6N/ANov 7, 2019$9.58M
    Jun 30, 2019-$0.08-$0.07-$0.08 - -$0.07-14.29%MissN/A6N/AAug 8, 2019$8.46M
    Mar 31, 2019-$0.08-$0.06N/A-33.33%MissN/A4N/AMay 2, 2019$6.65M
    Dec 31, 2018-$0.08-$0.07-$0.08 - -$0.05-14.29%MissN/A5N/AMar 7, 2019$5.69M
    Sep 30, 2018-$0.07-$0.07-$0.09 - -$0.070.00%In lineN/A5N/ANov 8, 2018$5.29M
    Jun 30, 2018-$0.09-$0.06-$0.07 - -$0.06-50.00%MissN/A4N/AAug 9, 2018$4.63M
    Mar 31, 2018-$0.07-$0.08-$0.10 - -$0.08+12.50%BeatN/A4N/AMay 3, 2018$4.02M
    Dec 31, 2017-$0.09-$0.07-$0.08 - -$0.04-28.57%MissN/A4N/AMar 6, 2018$3.32M
    Sep 30, 2017-$0.08-$0.07N/A-14.29%MissN/AN/AN/ANov 1, 2017$3.00M
    Jun 30, 2017-$0.08-$0.08N/A0.00%In lineN/AN/AN/AAug 8, 2017$2.92M
    Mar 31, 2017-$0.10-$0.12N/A+16.67%BeatN/AN/AN/AMay 4, 2017$2.71M
    Dec 31, 2016-$0.25-$0.28N/A+10.71%BeatN/AN/AN/AMar 13, 2017$2.23M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.92, after -$1.36 the year before. It was -$0.93 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.92N/A
    Dec 31, 2024-$1.36N/A
    Dec 31, 2023-$2.18N/A
    Dec 31, 2022-$0.90N/A
    Dec 31, 2021-$0.51N/A
    Dec 31, 2020-$0.66N/A
    Dec 31, 2019-$0.26N/A
    Dec 31, 2018-$0.31N/A
    Dec 31, 2017-$0.35N/A
    Dec 31, 2016-$0.93N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 4,900 words across 14 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20264,92614
    2026Q2Jun 30, 20263,58111
    2026Q1Mar 31, 20264,55715
    2025Q4Dec 31, 20254,90212
    2025Q3Sep 30, 20256,09313
    2025Q2Jun 30, 20255,45515
    2025Q1Mar 31, 20254,92512
    2024Q4Dec 31, 20245,77615

    2026Q3 Earnings Call

    Opening remarks

    Todd Fromer Host, KCSA Strategic Communications Thank you, operator. Before we begin today, I would like to remind everyone that this conference call contains certain forward-looking statements. All statements that address our operating performance, events, or developments we expect or anticipate occurring in the future are forward-looking statements. Forward-looking statements are based on management's beliefs and assumptions, and not on information currently available to our management team. Our management team believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date when made. We do not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events, and developments to differ materially from our historical experience and our present expectations or projections. These risks and uncertainties include, but are not limited to, those described in Item 1A, Risk Factors, and elsewhere in our annual report on Form 10-K filed with the Securities and Exchange Commission, and those described from time to time in the other reports that we file with the Securities and Exchange Commission. As a reminder, Cryoport has uploaded its third-quarter 2026 interview document to the main page of the Cryoport, Inc. website. This document provides a review of Cryoport's financial and operational performance and the general business outlook. Before I turn the call over to Jerry, please note that because of the strategic partnership that has been established with DHL Group and the related sale of CRYOPDP to DHL in June 2025, CRYOPDP's financials, which were previously a part of Cryoport's Life Sciences Services reportable segment, are now presented as discontinued operations. Please note that unless otherwise indicated, all revenue figures discussed today will refer to continuing operations. This includes Cryoport's fiscal year 2026 revenue guidance. It is now my pleasure to turn the call over to Mr. Jerrell W. Shelton, Chief Executive Officer of Cryoport. Jerry, the floor is yours.

    Jerrell W. Shelton Chief Executive Officer Thank you, Todd. Good afternoon, everyone. With me today is our Chief Financial Officer, Robert S. Stefanovich; our Chief Scientific Officer, Dr. Mark W. Sawicki; and our Vice President of Corporate Development and Investor Relations, Thomas J. Heinzen. I am pleased to report that Cryoport delivered another strong quarter, with revenue of $50.2 million, representing 14% year-over-year growth. Life Sciences Services continued to be a key growth driver, with revenue increasing 18% and representing 57% of our total company revenue.

    Frequently Asked Questions About CYRX

    When is Cryoport's next earnings date?

    Cryoport's next earnings report is expected for Mar 1, 2027.

    Did CYRX beat earnings estimates last quarter?

    No. Cryoport reported EPS of -$0.25 for the quarter ended Sep 30, 2026, below the -$0.19 estimate by 31.58%.

    What EPS do analysts expect from CYRX next quarter?

    The consensus EPS estimate for Cryoport for the quarter ending Dec 31, 2026 is -$0.18 from 11 analysts, with estimates from -$0.20 to -$0.17.

    How often does CYRX beat earnings estimates?

    Cryoport beat the EPS estimate in 2 of the last 8 quarters, with an average surprise of -9.33%.